Comparing Loteprednol Ophthalmic vs Restasis
| Loteprednol ophthalmic | Restasis (cyclosporine) |
|
|---|
| Loteprednol ophthalmic | Restasis (cyclosporine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Conjunctivitis, Dry Eye Disease, Iritis, Cyclitis, Allergies, Keratitis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Loteprednol ophthalmic may also... View more |
Prescription only
Prescribed for Dry Eye Disease. Restasis may also be used for purposes not listed in this medication guide. |
Related suggestions Dry Eye Disease (Keratoconjunctivitis Sicca)
|
|||||||||||||||
| More about Loteprednol ophthalmic | More about Restasis (cyclosporine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Loteprednol ophthalmic has an average rating of 7.5 out of 10 from a total of 37 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 24% reported a negative effect. |
Restasis has an average rating of 4.6 out of 10 from a total of 224 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Loteprednol ophthalmic side effects |
View all Restasis side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Loteprednol ophthalmic prices |
View all Restasis prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Alrex, Eysuvis, Inveltys, Lotemax, Lotemax SM | Other cyclosporine brands include: Cequa, Verkazia, Vevye | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 42 drugs are known to interact with Loteprednol ophthalmic:
|
A total of 15 drugs are known to interact with Restasis:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 15, 2011 |
December 23, 2002 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.